Reading time is <1 mins


First identified in Saudi Arabia in 2012, we have compiled for you all the details in our news about the MERS virus, which has spread to many other countries, including the United States, and is caused by a new corona virus.

Those over the age of 65, heart disease, kidney disease, respiratory disease, those with diabetes, a chronic disease such as those with congenital or Acquired Immune renal disease, malignant disease, end-stage disease, pregnant women and children under 12 years of age resides at risk of MERS disease; especially those who have weakened immune systems, older people, cancer and diabetes, in those with more severe chronic lung disease remains.

So, what is the MERS virus? Things to know about MERS symptoms and treatment:


Middle East Respiratory Syndrome (MERS) is a viral respiratory disease caused by a new corona virus (Middle East Respiratory Syndrome Corona virus or MERS ‐ CoV), first identified in Saudi Arabia in 2012. MERS-CoV is a zoonotic virus, meaning it is transmitted between animals and humans. Corona viruses are a large family of viruses that can cause diseases ranging from colds to Severe Acute Respiratory Syndrome (SARS).

Studies have shown that humans are infected through direct or indirect contact with infected camels. But it is not yet known exactly where and how the disease is transmitted to humans. It is believed that it may have originated from bats and infected camels for some time in a distant time, according to analysis of different virus genomes ( genetic code containing all instructions in a living being).

Retrospective (retrospective) research has subsequently found that the first known cases of MERS occurred in Jordan in April 2012.


MERS symptoms begin to appear about 5 or 6 days after a person is exposed, but can range from 2 to 14 days.

Typical MERS symptoms include fever, cough and shortness of breath. Pneumonia is common, but not always present. Gastrointestinal symptoms, including diarrhea, have also been reported. In some cases, bloody sputum has been observed. Some laboratory-approved cases of MERS-CoV infection have been reported as asymptomatic (symptom-free, silent, subclinical disease). But after a lab test, the MERS-CoV infection can be positive. Most of these asymptomatic cases have been identified following persistent contact monitoring of a laboratory-approved case. About 35% of patients with reported MERS-CoV infection died.


Because there is no special treatment for MERS-CoV, the treatment applied is supportive, aimed at preventing secondary infections and complications due to the fact that the virus is not fully known. People diagnosed with MERS-CoV can be monitored and treated in all hospitals that can provide mechanical respiratory support and respiratory isolation.


Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.


Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.


Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.


Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)